EA202190541A1 - POLYMER-ANTIBODY CONJUGATES TARGETED ON NaPi2b, DRUG AND METHODS OF THEIR APPLICATION - Google Patents

POLYMER-ANTIBODY CONJUGATES TARGETED ON NaPi2b, DRUG AND METHODS OF THEIR APPLICATION

Info

Publication number
EA202190541A1
EA202190541A1 EA202190541A EA202190541A EA202190541A1 EA 202190541 A1 EA202190541 A1 EA 202190541A1 EA 202190541 A EA202190541 A EA 202190541A EA 202190541 A EA202190541 A EA 202190541A EA 202190541 A1 EA202190541 A1 EA 202190541A1
Authority
EA
Eurasian Patent Office
Prior art keywords
napi2b
drug
polymer
methods
application
Prior art date
Application number
EA202190541A
Other languages
Russian (ru)
Inventor
Эрик П. Хейлмэн
Донна М. Ярленски
Дональд А. Бергстром
Original Assignee
Мерсана Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерсана Терапьютикс, Инк. filed Critical Мерсана Терапьютикс, Инк.
Priority claimed from PCT/US2019/046852 external-priority patent/WO2020037225A1/en
Publication of EA202190541A1 publication Critical patent/EA202190541A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

В изобретении описаны режимы дозирования для нацеленных на NaPi2b конъюгатов антитело-лекарственное средство для лечения злокачественной опухоли.The invention describes dosage regimens for NaPi2b targeting antibody-drug conjugates for the treatment of cancer.

EA202190541A 2019-05-30 2019-08-16 POLYMER-ANTIBODY CONJUGATES TARGETED ON NaPi2b, DRUG AND METHODS OF THEIR APPLICATION EA202190541A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962854701P 2019-05-30 2019-05-30
PCT/US2019/046852 WO2020037225A1 (en) 2018-08-17 2019-08-16 Napi2b-targeted polymer antibody-drug conjugates and methods of use thereof

Publications (1)

Publication Number Publication Date
EA202190541A1 true EA202190541A1 (en) 2021-06-09

Family

ID=76805197

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202190541A EA202190541A1 (en) 2019-05-30 2019-08-16 POLYMER-ANTIBODY CONJUGATES TARGETED ON NaPi2b, DRUG AND METHODS OF THEIR APPLICATION

Country Status (1)

Country Link
EA (1) EA202190541A1 (en)

Similar Documents

Publication Publication Date Title
PH12019502545A1 (en) Anti-cdh6 antibody and anti-cdh6 antibody-drug conjugate
PH12019501663A1 (en) Anti-gpr20 antibody and anti-gpr20 antibody-drug conjugate
EA202090776A1 (en) VISUALIZING AND RADIOTHERAPY AGENTS TARGETED ON FIBROBLAST-ACTIVATING PROTEIN ALPHA (FAPALPHA)
EA201790404A1 (en) MACROPINOCYTOZING HUMAN ANTI-CD46 ANTIBODIES AND TARGET TREATMENT OF CANCER
CY1123983T1 (en) AXL-SPECIFIC ANTIBODY-DRUG CONJUGATIONS FOR THE TREATMENT OF CANCER
WO2018022668A3 (en) Neuromodulating compositions and related therapeutic methods for the treatment of cancer
NZ741261A (en) Pyrrolobenzodiazepine antibody drug conjugates and methods of use
EA201800444A1 (en) DERIVATIVES OF MAYTANZINOID, THEIR CONJUGATES AND METHODS OF USE
EA201890009A1 (en) EZH2 INHIBITORS FOR TREATING LYMPHOMA
EA202190189A1 (en) A CROSS-LINKED DERIVATIVE OF PYRROLOBENZODIAZEPINE DIMER (PBD) AND ITS CONJUGATES
MX2021001924A (en) Napi2b-targeted polymer antibody-drug conjugates and methods of use thereof.
BR112019023246A8 (en) pharmacokinetic improvements of bifunctional chelates and uses thereof
CL2019002240A1 (en) Therapeutic dendrimers.
BR112021025699A2 (en) Anti-mesothelin antibodies and immunoconjugates thereof
EA201990567A1 (en) COMBINED THERAPY WITH GLUTAMINASE INHIBITORS
EA201991196A1 (en) SELF-ASSEMBLED DIBLO-COPOLYMERS CONSISTING OF PEGMEMA AND CARRYING MEDICINE OF POLYMERIC SEGMENTS
EA202191769A1 (en) TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES
EA201992658A1 (en) RECURRENT GLIOBLASTOMA TREATMENT METHODS (RGBM)
FR3096259B1 (en) Antibody-drug conjugates and their use in therapy
MX2023008849A (en) Combination therapy using a liv1-adc and a chemotherapeutic.
CY1126032T1 (en) ANTIBODY-DRUG CONJUGATIONS TARGETING UPARAP
BR112022000297A2 (en) Peptide conjugates of microtubule targeting agents as therapeutics
CY1124183T1 (en) ANTI-SEZ6 DRUG CONJUGATES AND METHODS OF USE
EA202091112A1 (en) SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION
PH12016502042A1 (en) Drug delivery conjugates for treating resistant cancer and for use in combination therapy